Latest News and Press Releases

Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improve

Borgarráð samþykkti á fundi sínum 8. janúar 2026 útgáfuáætlun Reykjavíkurborgar fyrir fyrri hluta ársins 2026. Samkvæmt samþykktri fjárhagsáætlun fyrir árið 2026 er gert ráð fyrir að lántaka...

Jan 4, 2026: AGM (AGMH) & Amber (AMBR) signed MOU for RWA tokenization. Amber to provide blockchain tech/support; subject to negotiation & regulations.

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall...

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative...

Chicago, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The global smart meter market size was valued at USD 30.19 billion in 2025 and is projected to hit the market valuation of USD 112.71 billion by 2035 at a...

ElevateBio Achieves Sixth Consecutive Year of Revenue Growth Driven by Expansion of its Genetic Medicine Technology and Manufacturing Business

Enrollment of pivotal cohort expected to begin in Q1 2026; ATSN-201 BLA submission on track for early 2028 DURHAM, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene...

Financing supports Phase 2 development of ALV-100, IND filing of ALV-200 and advancement of additional programs across the R&D pipeline ALV-100, a bifunctional GIPR antagonist / GLP-1R agonist,...

Announces 20th Acquisition